Midgard Science

Labs / Assays & in vitro testing

NeuroProof Systems GmbH

Rostock, Germany · neuroproof.com

NeuroProof Systems GmbH is a contract research organization in Rostock, Germany focused on CNS drug screening and neurotoxicity testing. It provides pre-clinical screening services for pharmaceutical, biological, and neurotoxicity applications using neuronal cell cultures, iPSC-derived neurons, and microelectrode array-based assays.

They take quote requests by email.

What they offer

  • Neurotoxicity

    Assesses neurotoxic threats using in vitro assays with primary neuronal cell cultures from mice, rats, and human iPSC-derived cell cultures.

  • Disease Models

    Develops and applies in vitro disease models for CNS drug discovery using primary neuronal cell cultures and human iPSC-derived neuronal cell cultures.

  • Functional Phenotypic Screening

    Performs phenotypic screening based on electrophysiological activity of complex neuronal cell systems.

  • Neuronal Maturation

    Uses MEA neurochip technology to monitor and characterize maturation of primary mouse or human iPSC-derived network activity.

  • Target validation

    Uses standard pharmacology methods to validate receptors in MEA experiments.

  • MEA Recording Services

    Conducts compound testing with microelectrode array recordings and advanced data analysis, including concentration-response curves and substance database comparison.

  • Imaging

    Provides automated imaging services for higher-throughput phenotypic screening.

  • Stem Cell Services

    Supports iPSC-derived neuronal cell culture projects and neuronal stem cell culture protocol optimization.

  • Biologics and AAV Testing

    Tests AAV constructs in disease modeling and AAV libraries as a service.

  • Data Analysis Services

    Provides spike train analysis and other data analysis services for MEA recordings.

  • Glutamate Excitotoxicity Assay

    Uses primary frontal cortex cultures or human iPSC-derived tri-cultures to model glutamate excitotoxicity and related neurodegenerative mechanisms.

  • Alzheimer’s Functional Phenotypic Disease Model

    Studies early functional effects of Abeta42 on neuronal network activity and rescue by test compounds.

  • Parkinson's Disease In Vitro Disease Models and PD Screening Assays

    Models Parkinson’s disease using agents such as MPP+, alpha-synuclein, and disease-associated mutations or patient-derived iPSC models.

What they work on

Modalities
Small molecule, Peptide, Viral vector, Cell therapy
Species and models
mouse, rat, human iPSC-derived cell cultures, primary neuronal cell cultures, primary frontal cortex cultures, primary mouse hippocampal neurons, primary mouse midbrain cultures, dopaminergic neuronal cultures, glutamatergic neurons, GABAergic neurons, astrocytes
Assays and studies
MEA-based phenotypic screening, spontaneous network activity recording, compound-induced network activity recording, concentration-response experiments, substance database comparison, spike train analysis, hyperexcitation pattern recognition, viability assay, apoptosis assay, oxidative stress assay, cell viability and cytotoxicity, ALS biomarker assays, and 1 more
Instruments and platforms
Maestro MEA System from Axion Biosystems, MEA neurochips
Scale and capacity
medium-throughput screening, thousands of experiments, hundreds of projects
Therapeutic areas
CNS drug discovery, neurotoxicity, Alzheimer's disease, Parkinson's disease, epilepsy, amyotrophic lateral sclerosis (ALS), Fragile X syndrome, schizophrenia, neuropathic pain, HIV-associated neurodegenerative disorders, Huntington's disease, autism, and 1 more
Turnaround
short turn around time
Type
CRO
Sites
Rostock, Germany
Serves
North America, Europe, Asia

Similar labs. MedChem Partners, Aurigene Pharmaceutical Services, Biofidus GmbH, Bioneeds

Found in a contract services directory. Listing built from neuroproof.com. Work here? Claim this listing.

NeuroProof Systems GmbH · Midgard Science